Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

PCGF6 Activators

PCGF6, a component of the Polycomb group (PcG) proteins, plays a pivotal role in the chromatin-modifying complexes involved in transcriptional repression. The chemical class known as PCGF6 Activators encompasses a range of compounds that, while not necessarily targeting PCGF6 directly, can influence the protein's activity or the intricate pathways it is associated with, usually by modulating the chromatin environment.

Among these activators, DNA methyltransferase inhibitors such as 5-Azacytidine and RG108 can modulate the chromatin state, thereby possibly affecting PCGF6 activity. Similarly, histone deacetylase (HDAC) inhibitors like Trichostatin A and Vorinostat work by enhancing histone acetylation. This modification, in turn, has the potential to indirectly influence PCGF6-associated pathways by altering chromatin structure and accessibility. Another influential group within this chemical class targets histone methyltransferases. BIX-01294, for instance, inhibits G9a, while EPZ-6438 focuses on EZH2. By changing histone methylation patterns, these compounds can impact pathways that PCGF6 is intertwined with. BET bromodomain inhibitors like JQ1 and I-BET151 are notable as they modify chromatin accessibility, which can have downstream effects on PCGF6's functionality. Lastly, Anacardic Acid, a histone acetyltransferase inhibitor, can further influence chromatin dynamics, making its mark on the intricate web of pathways that PCGF6 is part of.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor; can modulate chromatin state, potentially influencing PCGF6 activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor; enhances histone acetylation which can indirectly influence PCGF6-associated pathways.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC inhibitor; can modify chromatin structure, potentially affecting PCGF6.

BIX01294 hydrochloride

1392399-03-9sc-293525
sc-293525A
sc-293525B
1 mg
5 mg
25 mg
$37.00
$112.00
$408.00
(1)

Inhibits histone methyltransferase G9a; changes in methylation can impact PCGF6-related pathways.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

DNA methyltransferase inhibitor; may indirectly alter PCGF6 functionality through epigenetic modifications.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

Inhibitor of histone methyltransferase EZH2; might influence pathways associated with PCGF6.

UNC0638

1255580-76-7sc-397012
10 mg
$315.00
(0)

G9a and GLP histone methyltransferase inhibitor; can modify chromatin state, potentially impacting PCGF6.

3-Deazaneplanocin, HCl salt

120964-45-6sc-351856
sc-351856A
sc-351856B
1 mg
5 mg
10 mg
$256.00
$612.00
$936.00
2
(1)

EZH2 inhibitor; could modify the epigenetic landscape, indirectly influencing PCGF6.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

HDAC inhibitor; its influence on chromatin remodeling can indirectly impact PCGF6.

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$102.00
$204.00
13
(1)

Histone acetyltransferase inhibitor; can influence chromatin dynamics, potentially affecting PCGF6.